Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial
Hongru Yang(Affiliated Hospital of Southwest Medical University), Jingbo Wu(Affiliated Hospital of Southwest Medical University), Bangxian Tan(Affiliated Hospital of North Sichuan Medical College), Qinglian Wen(Southwest Medical University), Jinfeng Rong(Affiliated Hospital of Southwest Medical University), Qiaoli Liu(Affiliated Hospital of Southwest Medical University), Defeng Hu(Chengdu Military General Hospital), Haowen Pang(Affiliated Hospital of Southwest Medical University), Xin Chen(Shandong University of Traditional Chinese Medicine), Shan Xu(Houston Methodist), Tao Zhang(First Affiliated Hospital of Jinan University), Yu Zhang(Rutgers, The State University of New Jersey), Ling Zhang(Hebei Medical University), Xinping Zhang(Huazhong University of Science and Technology), Jianwen Zhang(Northwest Normal University), Shiming Wen(Nanchong Central Hospital), Sheng Lin(Guangzhou Medical University), Daiyuan Ma(North Sichuan Medical University), Lijia He(Stomatology Hospital), Xiaoyang Sun(Affiliated Hospital of Southwest Medical University), Chang-Ling Shang(Affiliated Hospital of Southwest Medical University), Peirong Ren(Affiliated Hospital of Southwest Medical University), Xiangxiang Shi(Affiliated Hospital of Southwest Medical University), Xiaobo Du(Mianyang Central Hospital), Juan Fan(Affiliated Hospital of Southwest Medical University), Mi Yang(Nanfang Hospital)
Cited by 104
Related Papers
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|849
A Quartet of PIF bHLH Factors Provides a Transcriptionally Centered Signaling Hub That Regulates Seedling Morphogenesis through Differential Expression-Patterning of Shared Target Genes in Arabidopsis
|PLoS Genetics|2013|415
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2022|267